⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QGEN News
QIAGEN N.V.
Global Magnetic Beads Market Size, Share, Trends, and Forecast by Type, Application, and Region, 2026-2034 | NGS and Diagnostics Drive 9.88% CAGR Toward USD 6.8 Billion
globenewswire.com
BIO
QGEN
TMO
Europe Non-Viral Transfection Reagents Market Forecast to 2035 by Method, Application, and End-User | mRNA and Cell Therapy Fuel 5.7% CAGR and USD 0.40 Billion Opportunity
globenewswire.com
QGEN
Australia Precision Genomics Market Size, Share, Trends and Forecast to 2035 | AI, NGS, and Public Funding Fuel 13.2% CAGR and a US$1.01 Billion Opportunity
globenewswire.com
TXG
AGNC
BGI
ILMN
ONT
PACB
QGEN
TMO
Global Residual DNA Testing Market Size, Share, Trends, and Forecast, 2026-2033 | Biologics and Gene Therapy Growth Fuels 6.8% CAGR to USD 525.3 Million
globenewswire.com
TMO
MRK
CRL
BIO
QGEN
MRVI
DNA Sequencing Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $91.9 Billion as Next-Generation Sequencing Expands Oncology and Rare Disease Diagnostics
globenewswire.com
TMO
A
ILMN
QGEN
ONT
PACB
MYGN
Liquid Biopsy with Emphasis on Cancer Market to Reach $8.0 Billion by 2031, Driven by Rising Cancer Incidence and Precision Medicine Adoption
globenewswire.com
GH
NTRA
EXAS
ILMN
TMO
QGEN
MYGN
PSNL
FRNM
Global Exosome Market Size, Share, Trends, Clinical Trials, and Forecast, 2026-2034 | Diagnostics Growth and Therapeutic Approvals Unlock Investment Opportunities
globenewswire.com
TMO
QGEN
MDXH
Global Precision Medicine Market Size, Share, Trends, and Forecast, 2026-2033 | AI, Genomics, and Companion Diagnostics Propel 16.99% CAGR to $405.10 Billion
globenewswire.com
ILMN
DGX
MYGN
MDT
GEHC
ABT
QGEN
Global Exosomes Market Size, Share, Trends, and Forecast, 2026-2033 | Market to Reach $1.2 Billion at 23.0% CAGR as Liquid Biopsy and Drug Delivery Opportunities Expand
globenewswire.com
TECH
DHR
HOLX
QGEN
TMO
Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership
globenewswire.com
TMO
MRK
QGEN
AGNC